Page last updated: 2024-10-31

midodrine and Hospital-Acquired Condition

midodrine has been researched along with Hospital-Acquired Condition in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research Excerpts

ExcerptRelevanceReference
"Orthostatic hypotension is more frequent in polymedicated elderly patients with co-morbidities (prevalence 23%)."2.48[Orthostatic hypotension: implications for the treatment of cardiovascular diseases]. ( Mansourati, J, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mansourati, J1

Reviews

1 review available for midodrine and Hospital-Acquired Condition

ArticleYear
[Orthostatic hypotension: implications for the treatment of cardiovascular diseases].
    Presse medicale (Paris, France : 1983), 2012, Volume: 41, Issue:11

    Topics: Age Factors; Aged; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular Diseases; Contrain

2012